Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

NIH 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 8Prostatic Neoplasms 5Polycystic Ovary Syndrome 5Multiple Myeloma 5Colorectal Neoplasms 5Small Cell Lung Carcinoma 4Rectal Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Stomach Neoplasms 2Pancreatic Neoplasms 2Fibrosis 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Breast Carcinoma In Situ 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Urinary Bladder Neoplasms 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Thrombosis 1Sprains and Strains 1Smoldering Multiple Myeloma 1Sepsis 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 86atezolizumab 80pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 44Radiofrequency Ablation 44Hepatectomy 43Leucovorin 41camrelizumab 40Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28Gemcitabine 26Cyclophosphamide 26cabozantinib 25Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Simvastatin × Clear all
NCT02968810 2026-05-04

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

National Cancer Institute (NCI)

Phase 2 Active not recruiting
52 enrolled 15 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT03654053 2026-01-07

SACRED

VA Office of Research and Development

Phase 3 Active not recruiting
142 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡